Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Hanna Persson, Head of Sales, Ress Capital

    Secondary Life Markets April 13, 2023By Greg Winterton
    Life Risk News Q&A
    Share
    Twitter LinkedIn Email

    Stockholm-based asset manager Ress Capital is a specialist investor in life settlements and runs one of the few listed vehicles active in the space. Greg Winterton spoke to Hanna Persson, Head of Sales at Ress Capital, to learn more about the firm itself and its approach to the space.

    GW: Hanna, Ress Capital’s investment vehicle is publicly listed, on the Nasdaq Nordic exchange. Why did the firm decide to go that route?

    HP: The open-ended structure enables gradual growth, and policies can be gradually sourced. It also allows the fund to buy longer life expectancies which a closed-end fund could not do with a buy and hold strategy. We wanted to make this very interesting asset class more accessible to investors that would not necessarily be able to invest in the life settlement market otherwise. Being listed allows different type of investors from all over the world to buy shares easily through their local bank/broker.

    GW: Tell us about your approach to policy selection. What are some of the features that you look for in policies that make it into your portfolio, and why?

    HP: In the end, using correct mortality assumptions will of course be most important and we tend to be on the conservative side there. But for policy selection, our investment team focuses on limiting the tail risk of the portfolio both at an individual policy as well as portfolio level. This is achieved by reviewing large numbers of policies and then buying single, high-quality policies. We are very selective and buy only 3-4% of the policies we look at.

    Hannah Persson
    Hanna Persson

    In general, we look for wealthier and relatively healthy individuals with long life expectancies (average life expectancy at purchase is 12 years) which we believe are more accurate. Then, by looking for stable future premium streams, the negative effect of any individual substantially outliving their life expectancy is reduced.

    At a portfolio level, we then always strive to have high level of diversification in terms of age, gender, size and life expectancy which should reduce the systemic risk of medical underwriters estimating longevity for sub-groups.

    GW: Ress Capital is a signatory to the United Nations’ Principles for Responsible Investments. Why did you decide to pursue this credential and what’s been the main benefit so far?

    HP: Being a responsible investor is an integral part of how we operate. Our clients should feel confident that we prioritise sustainability in our daily activities and that we always strive to improve our sustainability efforts. Being an alternative investment manager active in the secondary market for US life insurance policies, ethics is a key aspect.

    At Ress Capital, we are convinced that the future challenges we face will place new demands on us as managers of our clients’ capital. Through our work with responsible investments, we want to contribute to a more long-term and sustainable investment climate where environmental, social, and corporate governance (ESG) factors are included in the investment process. Responsible investments thus become an important prerequisite for achieving our goal of generating good long-term returns.

    As an essential part of Ress Capital’s commitment to sustainability and responsible investments, we signed the United Nations’ Principles of Responsible Investment (UNPRI) in 2017 meaning we supports the work carried out by UNPRI to promote sustainability work in the asset management industry.

    GW: There is disagreement amongst life settlement-focused investment managers about whether the asset class should be considered more akin to private equity or alternative credit. What’s Ress Capital’s view and why?

    HP: I wouldn’t say Ress Capital has taken any official stance on this. However, we believe the asset class potentially has similarities with alternative credit, although we would argue that the credit rating of US life insurance companies is far better and they’re also highly regulated. As regards similarities with private equity, since our fund is listed, it has little in common with closed-end PE funds with no liquidity. Also, we would argue that expected return profile is quite different from PE. 

    GW: Lastly, Hanna, what’s your message to institutional, end investors that don’t have an allocation to life settlements in their portfolio – what are the main reasons for doing so in your view?

    HP: This is an asset class that is fundamentally uncorrelated to majority of other asset classes. The underlying risk is decoupled from the economic cycle. When done correctly, life settlements as an asset class offers a fixed income alternative with yields comparable to those of an equity portfolio, but with volatility below that of investment grade bonds. In times of high volatility in the market life settlements present a unique, stable and truly uncorrelated return stream.

    Hanna Persson is Head of Sales at Ress Capital

    2023 - April Life Settlements Longevity Risk Q&A Volume 2 Issue 4 - April 2023
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026By LMI Newsdesk

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026By LMI Newsdesk

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026By LMI Newsdesk

    The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

    February 9, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.